APPLIED DNA SCIENCES INC Business Finance Contracts & Agreements
119 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Exchange Agreements (2)
- Guaranty Agreements (1)
- Note Agreements (11)
- Purchase Agreements (17)
- Registration Rights Agreements (10)
- Security Agreements (17)
- Share Agreements (1)
- Stock Agreements (1)
- Subscription Agreements (7)
- Term Sheets (2)
- Trust Agreements (1)
- Underwriting Agreements (9)
- Warrant Agreements (39)
- Form of Securities Purchase Agreement, dated January 31, 2024, by and between Applied DNA Sciences, Inc. and the parties thereto (Filed With SEC on February 1, 2024)
- Form of Private Common Warrant (Filed With SEC on February 1, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 1, 2024)
- Equity Distribution Agreement, dated November 7, 2023, by and between Applied DNA Sciences, Inc. and Maxim Group LLC (Filed With SEC on November 7, 2023)
- Share Purchase Agreement, dated July 12, 2023, by and among Spindle Acquisition Corp., Spindle Biotech Inc., the persons listed on Schedule 1.1 therein, Lai Him Chung and Applied... (Filed With SEC on July 13, 2023)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 28, 2023)
- Form of Securities Purchase Agreement, dated August 4, 2022, by and between Applied DNA Sciences, Inc. and certain purchasers (Filed With SEC on August 9, 2022)
- Form of Prefunded Warrant (Filed With SEC on August 9, 2022)
- Form of Series B Warrant (Filed With SEC on August 9, 2022)
- Form of Series A Warrant (Filed With SEC on August 9, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on August 1, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 1, 2022)
- Form of Series B Warrant (Filed With SEC on August 1, 2022)
- Form of Series A Warrant (Filed With SEC on August 1, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on February 23, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on January 11, 2021)
- Letter Agreement, dated October 9, 2020, by and among Applied DNA Sciences, Inc., Dillon Hill Capital, LLC, and Delaware Trust Company, as Collateral Agent (Filed With SEC on October 14, 2020)
- Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)
- Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 14, 2020)
- Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)
- Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)
- Warrant Agreement, dated November 15, 2019, between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 18, 2019)
- Form of pre-funded warrant (Filed With SEC on November 14, 2019)
- Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 14, 2019)
- Underwriting Agreement entered into by and between Applied DNA Sciences, Inc. and Maxim Group LLC, as Representative of the Underwriters listed in Schedule I hereto, dated... (Filed With SEC on November 14, 2019)
- Form of Underwriting Agreement (Filed With SEC on November 8, 2019)
- Form of Underwriting Agreement (Filed With SEC on November 1, 2019)
- Form of pre-funded warrant (Filed With SEC on October 25, 2019)
- Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on October 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 25, 2019)
- Form of Subscription Agreement between investors and Applied DNA Sciences, Inc., dated August 22, 2019 (Filed With SEC on August 26, 2019)
- Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by APDN (B.V.I.) Inc. in favor of Delaware Trust Company as collateral agent for the secured... (Filed With SEC on August 13, 2019)
- Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by the Company in favor of Delaware Trust Company as collateral agent for the secured parties... (Filed With SEC on August 13, 2019)
- Asset Purchase Agreement, dated July 29, 2019 by and between LineaRX, Inc. and Vitatex Inc (Filed With SEC on August 12, 2019)
- Amendment to Secured Convertible Notes, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investors named on the signature page thereof (Filed With SEC on July 17, 2019)
- Securities Purchase Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)
- Registration Rights Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)